Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China flag China · Delayed Price · Currency is CNY
29.58
-0.30 (-1.00%)
At close: May 9, 2025, 2:57 PM CST

SHE:001367 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
May '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 2018 - 2019
Market Capitalization
3,0582,7962,989---
Upgrade
Market Cap Growth
23.44%-6.46%----
Upgrade
Enterprise Value
2,0381,8322,063---
Upgrade
Last Close Price
30.3927.2429.31---
Upgrade
PE Ratio
25.7522.8228.56---
Upgrade
PS Ratio
6.455.937.52---
Upgrade
PB Ratio
2.222.082.39---
Upgrade
P/TBV Ratio
2.252.112.43---
Upgrade
P/FCF Ratio
34.4027.31128.99---
Upgrade
P/OCF Ratio
16.4416.7337.08---
Upgrade
EV/Sales Ratio
4.303.895.19---
Upgrade
EV/EBITDA Ratio
15.4513.9018.18---
Upgrade
EV/EBIT Ratio
17.7515.7020.45---
Upgrade
EV/FCF Ratio
22.9217.8989.04---
Upgrade
Debt / Equity Ratio
0.010.0100.000.00-
Upgrade
Debt / EBITDA Ratio
0.060.060.000.010.01-
Upgrade
Debt / FCF Ratio
0.090.080.010.010.02-
Upgrade
Asset Turnover
0.330.330.420.810.930.80
Upgrade
Inventory Turnover
2.262.051.572.152.472.25
Upgrade
Quick Ratio
10.529.3312.903.532.462.33
Upgrade
Current Ratio
11.6510.3114.955.353.513.46
Upgrade
Return on Equity (ROE)
9.04%9.45%12.18%25.91%29.36%23.04%
Upgrade
Return on Assets (ROA)
5.01%5.16%6.62%12.59%15.61%12.49%
Upgrade
Return on Capital (ROIC)
5.35%5.61%7.34%15.77%20.45%16.27%
Upgrade
Return on Capital Employed (ROCE)
8.20%8.60%8.00%21.80%28.00%24.80%
Upgrade
Earnings Yield
3.94%4.38%3.50%---
Upgrade
FCF Yield
2.91%3.66%0.78%---
Upgrade
Dividend Yield
0.56%0.62%1.15%---
Upgrade
Payout Ratio
28.24%27.74%-0.66%17.48%85.77%
Upgrade
Buyback Yield / Dilution
-2.99%-9.35%-22.74%0.02%-0.15%
Upgrade
Total Shareholder Return
-2.43%-8.73%-21.59%0.02%-0.15%
Upgrade
Updated Oct 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.